跳至主要内容
临床试验/CTIS2023-506108-23-00
CTIS2023-506108-23-00进行中(未招募)1 期

D6970C00004

Astrazeneca AB0 个研究点目标入组 28 人开始时间: 2023年11月8日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

招募中
1 期
An Open-label, Single-group, Three-period, Fixed-sequence, Phase I Study to Assess the Pharmacokinetics of AZD6793 Tablets When Administered Alone and in Combination with Itraconazole Capsules in Healthy Adult Female and Male ParticipantsChronic obstructive pulmonary diseaseMedDRA version: 26.1Level: PTClassification code: 10009033Term: Chronic obstructive pulmonary disease Class: 100000004855
CTIS2023-509002-30-00AstraZeneca AB16
进行中(未招募)
1 期
PET study of changes in [11C]AZ14132516 uptake following administration of multiple AZD7798 doses to patients with Crohn’s disease.Crohn's disease
CTIS2024-512992-11-00AstraZeneca AB12
招募中
1 期
Phase I study of AZD9592 in solid tumorsRecurrent or metastatic Head and NeckSquamous Cell Carcinoma of the oral cavity,oropharynx, hypopharynx or larynx, Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Metastatic Colorectal CancerMedDRA version: 20.0Level: LLTClassification code: 10079440Term: Non-squamous non-small cell lung cancer Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10001160Term: Adenocarcinoma lung Class: 10029104MedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10052358Term: Colorectal cancer metastatic Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10060121Term: Squamous cell carcinoma of head and neck Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10041826Term: Squamous cell carcinoma of lung Class: 100000004864
CTIS2022-501570-18-00Astrazeneca AB626
招募中
1 期
PET study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to healthy participants and patients with Crohn’s diseaseCrohn's Disease
CTIS2023-505471-78-00Astrazeneca AB14
招募中
1 期
A study to investigate the effect of oral ticagrelor on the pharmacokinetics of oral rosuvastatin when given in healthy participantsClinical trial healthy volunteerMedDRA version: 26.0Level: LLTClassification code: 10088820Term: Clinical trial healthy volunteer Class: 100000004848
CTIS2024-512197-99-00AstraZeneca AB28